Levamisole as an immunotherapeutic agent in the treatment of cancer.
D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy; D006224:Cricetinae; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007978:Levamisole / Q000276:immunology / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats
D007978:Levamisole
Ann N Y Acad Sci. 1976;277(00):260-8
793481
Cancer Treat Rev. 1977 Sep;4(3):167-94
589606
Acta Allergol. 1975 Apr;30(1):9-18
125516
Acta Radiol Ther Phys Biol. 1976 Apr;15(2):142-8
937058
Lancet. 1976 Jan 31;1(7953):211-5
55529
Lancet. 1975 Feb 22;1(7904):464
48661
Cancer Chemother Rep. 1975 May-Jun;59(3):531-6
128409
Br Med J. 1975 Aug 23;3(5981):461-4
1098727